| A review of the pathophysiological mechanisms underlying castration-resistant prostate cancer F Crowley, M Sterpi, C Buckley, L Margetich, S Handa, Z Dovey Research and Reports in Urology, 457-472, 2021 | 45 | 2021 |
| Targeting DNA damage repair pathways in pancreas cancer F Crowley, W Park, EM O’Reilly Cancer and Metastasis Reviews 40 (3), 891-908, 2021 | 25 | 2021 |
| Prostate cancer in transgender women: considerations for screening, diagnosis and management F Crowley, M Mihalopoulos, S Gaglani, AK Tewari, CK Tsao, M Djordjevic, ... British Journal of Cancer 128 (2), 177-189, 2023 | 17 | 2023 |
| Exploiting somatic alterations as therapeutic targets in advanced and metastatic cervical cancer FJ Crowley, RE O'Cearbhaill, DC Collins Cancer treatment reviews 98, 102225, 2021 | 15 | 2021 |
| Adherence to NCCN genetic testing guidelines in pancreatic cancer and impact on treatment F Crowley, S Gandhi, M Rudshteyn, M Sehmbhi, DJ Cohen The Oncologist 28 (6), 486-493, 2023 | 8 | 2023 |
| Does the 21-gene recurrence score have clinical utility in HR+/HER2+ breast cancer? N Bilani, F Crowley, M Mohanna, M Itani, M Yaghi, D Saravia, I Jabbal, ... The Breast 66, 49-53, 2022 | 2 | 2022 |
| Evaluating the role of aromatase inhibitors in the treatment of low-grade endometrial stromal sarcomas F Crowley, KA Cadoo, S Chiang, DL Mandelker, R Bajwa, A Iasonos, ... Gynecologic Oncology Reports 40, 100980, 2022 | 2 | 2022 |
| A phase II study of durvalumab and stereotactic ablative body radiotherapy (SABR) in locally advanced pancreatic adenocarcinoma (LA PDAC). F Keane, JD Schoenfeld, F Crowley, CA O'Connor, C White, C Schwartz, ... Journal of Clinical Oncology 41 (4_suppl), 725-725, 2023 | 1 | 2023 |
| Adjuvant modified FOLFIRINOX (mFFX) for resected pancreatic cancer (PDAC): Real world outcomes (RWO). F Keane, F Balogun, C O'Connor, F Crowley, A Chan, D Cowzer, JF Chou, ... Journal of Clinical Oncology 41 (4_suppl), 685-685, 2023 | 1 | 2023 |
| Evaluating the role of aromatase inhibitors (AIs) in the treatment of endometrial stromal sarcomas (ESS). F Crowley, KA Cadoo, S Chiang, JJ Mueller, ML Hensley, ... Journal of Clinical Oncology 39 (15_suppl), 5575-5575, 2021 | 1 | 2021 |
| Ocular side effects of anticancer agents used in the treatment of gynecologic cancers F Crowley, S Broderick, JH Francis, RE O'Cearbhaill, J Canestraro Gynecologic Oncology 188, 147-157, 2024 | | 2024 |
| Adjuvant mFOLFIRINOX (mFFX) for resected pancreatic cancer (PC): Long term clinical and genomic outcomes. F Keane, D Moss, CA O'Connor, M Perry, JF Chou, F Crowley, P Saxena, ... Journal of Clinical Oncology 42 (16_suppl), 4170-4170, 2024 | | 2024 |
| Comparison of chemotherapy to chemo-immunotherapy as first-line treatment in patients with advanced large cell neuroendocrine carcinomas (LCNECs) of mixed histology: A multi … K Matteson, A Nassar, TJ Ellis-Caleo, EC Mingo, V Aggarwal, A Sridhar, ... Journal of Clinical Oncology 42 (16_suppl), 8602-8602, 2024 | | 2024 |
| Patterns of referral to supportive oncology (SO) practice embedded in a cancer center and impact of timing of referrals on end-of-life outcomes. F Crowley, L Zeng, T Sheng, N Bilani, M Hobensack, B Popp, D Afezolli, ... Journal of Clinical Oncology 42 (16_suppl), e24064-e24064, 2024 | | 2024 |
| Exploring systemic treatment approaches for advanced pure large cell neuroendocrine carcinoma (LCNEC): A multicenter retrospective analysis. A Nassar, K Matteson, F Ardeshir, JE Gray, J Baena Espinar, ... Journal of Clinical Oncology 42 (16_suppl), 8106-8106, 2024 | | 2024 |
| Optimizing care in early phase cancer trials: The role of palliative care F Crowley, R Sheppard, S Lehrman, E Easton, TU Marron, D Doroshow, ... Cancer Treatment Reviews, 102767, 2024 | | 2024 |
| Finding the Balance: Treating Cancer Related Pain in Patients with Opioid Use Disorder F Crowley, J DiBiase, C Kuwata Journal of Pain and Symptom Management 67 (5), e739-e740, 2024 | | 2024 |
| GLP-1 receptor agonist as an effective treatment for breast cancer-related lymphedema: a case report F Crowley, MD Brown, EJ Gallagher, J Dayan Frontiers in Oncology 14, 1392375, 2024 | | 2024 |
| Outcomes in Premenopausal Patients with HR+/HER2− Breast Cancer and Lymph Node Micrometastasis Based on the 21-Gene Recurrence Score N Bilani, R Patel, F Crowley, A Tiersten The Oncologist 28 (12), 1049-1054, 2023 | | 2023 |
| Clinical utility of next generation sequencing (NGS) on circulating tumor DNA (ctDNA) in patients (pts) with pancreatic cancer (PC). F Keane, L Saadat, C O'Connor, JF Chou, AR Brannon, D Cowzer, ... Journal of Clinical Oncology 41 (16_suppl), 4154-4154, 2023 | | 2023 |
